Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (10): 1374-1382.doi: 10.12092/j.issn.1009-2501.2025.10.009

Previous Articles     Next Articles

The mechanism of polygonatum polysaccharide inducing the differentiation of tendon stem cells into chondrocytes through TGF-β3/Smad2 signaling pathway

CHEN Junjie1, YANG Dujiang1, HE Jiayang2, YUAN Xintong2, LIU Yingqi3, YANG Jiexiang4, WANG Guoyou1,5, PENG Teng6, SHEN Huarui1,5   

  1. 1Department of Joint Surgery, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China; 2Southwest Medical University, Luzhou 646000, Sichuan, China; 3College of Materials and Energy, Southwest University; Affiliated Hospital of Southwest University, Chongqing 404100, China; 4Department of Spinal Surgery, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China; 5Department of Orthopedics, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University; Key Laboratory of Orthopedic Diseases in Luzhou City, Luzhou 646000, Sichuan, China; 6School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 610000, Sichuan, China
  • Received:2024-12-12 Revised:2025-04-06 Online:2025-10-26 Published:2025-10-15

Abstract:

AIM: To verify the effect of polygonatum polysaccharide (PSP) combined with TGF-β3 in inducing the differentiation of rat tendon-derived stem cells (TDSCs) into chondrocytes by activating the TGF-β3/Smad2 pathway. METHODS: TDSCs were extracted from rat tail tendons using enzyme digestion, purified, passaged, and identified via flow cytometry. TDSCs were treated with different concentrations of PSP, and the optimal growth concentration was determined using the CCK-8 assay. TDSCs were divided into four groups: PSP, TGF-β3, PSP+TGF-β3, and Control for differentiation induction. Chondrogenic differentiation was evaluated using morphological observations, toluidine blue staining, immunofluorescence staining, and Western blot analysis to detect COLⅡ, SOX9, and AGG. Western blot was also used to measure the expression levels of Smad2 and p-Smad2 to evaluate the activation of the TGF-β3/Smad2 pathway after chondrogenic induction. RESULTS: Flow cytometry analysis showed that TDSCs highly expressed CD90 and CD29, while CD11b and CD45 expression was low. The CCK-8 assay indicated that 5 μmol/L PSP was the optimal intervention dose. Toluidine blue staining revealed that the blue staining area in the PSP, PSP+TGF-β3, and TGF-β3 groups was larger compared to the Control group. Immunofluorescence analysis demonstrated that COLⅡ expression was significantly increased in the PSP, TGF-β3, and PSP+TGF-β3 groups, with the highest expression in the PSP+TGF-β3 group (P<0.05). Western blot analysis showed that the levels of p-Smad2/Smad2, COLⅡ, SOX9, and AGG were elevated in the PSP, TGF-β3, and PSP+TGF-β3 groups, with the highest expression in the PSP+TGF-β3 group (P<0.05). Compared to the Control group, the TGF-β3 and PSP groups also showed significantly increased expression (P<0.05). CONCLUSION: PSP promotes the proliferation and chondrogenic differentiation of TDSCs, possibly by activating the TGF-β3/Smad2 pathway.

Key words: cartilage injury, polysaccharides from polygonatum, TGF-β3/Smad2 signalling pathway, tendon stem cells, chondrogenic induction

CLC Number: